A detailed history of Granite Shares Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Granite Shares Advisors LLC holds 1,327 shares of UTHR stock, worth $394,862. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,327
Previous 1,275 4.08%
Holding current value
$394,862
Previous $393,000 3.05%
% of portfolio
0.26%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 17, 2025

BUY
$276.47 - $328.4 $14,376 - $17,076
52 Added 4.08%
1,327 $381,000
Q1 2025

Apr 16, 2025

BUY
$304.42 - $380.78 $6,392 - $7,996
21 Added 1.67%
1,275 $393,000
Q4 2024

Feb 04, 2025

BUY
$348.66 - $410.0 $437,219 - $514,140
1,254 New
1,254 $442,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $13.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.